Prime Medicine Inc. PRME
$2.88
▼ -1.60% 24H
About
Prime Medicine Inc. is a biotechnology company dedicated to developing one-time curative genetic therapies using its proprietary Prime Editing platform. This versatile, precise, and efficient gene editing technology enables targeted modifications at specific genomic sites without inducing double-strand DNA breaks, pote…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees146
TickerPRME
Statistics
Market Cap$520.2M
Revenue (TTM)$4.6M
Net Income-$201.1M
Net Margin-4342.4%
EPS$-1.35
P/E-2.09
P/S128.95
P/B6.78
EV/EBITDA-2.51
ROE-216.1%
Dividend Yield—
Price$2.88
Data: Twelve Data · Revenue = mcap / P/S